Drag a card by its title · ⚙ to size, swap or remove

Who

Adam Lezack

Director

Company insider

Files Form 4 as: Director, Beta Bionics.

Every Form 4 they filed

In numbers

Trades disclosed: 14
Buys: 0
Sells: 4
Bought: $0
Sold: $122K
Companies: 1
Companies where not an officer: 1
First trade: 31 Jan 2025
Last trade: 22 May 2026
Last filed: 26 May 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies

BBNX Beta BionicsDirector · Medical Devices · last 22 May 20260 buys · 4 sells

Activity over time

1 Oct 2025 – 1 Oct 2026

Buys above the line, sells below, each month.

Every trade

Traded	Company	What	Amount
22 May 2026filed 26 May 2026	BBNX Beta BionicsMedical Devices	SEC FORM 4 Sold	$11K998 at $11.21	filing
22 May 2026filed 26 May 2026	BBNX Beta BionicsMedical Devices	SEC FORM 4 Sold	$11K998 at $11.21	filing
21 May 2026filed 26 May 2026	BBNX Beta BionicsMedical Devices	SEC FORM 4 Sold	$9,9501,000 at $9.95	filing
21 May 2026filed 26 May 2026	BBNX Beta BionicsMedical Devices	SEC FORM 4 Code A	—16,965 at $0.00	filing
21 May 2026filed 26 May 2026	BBNX Beta BionicsMedical Devices	SEC FORM 4 Sold	$9,9501,000 at $9.95	filing
21 May 2026filed 26 May 2026	BBNX Beta BionicsMedical Devices	SEC FORM 4 Code A	—16,965 at $0.00	filing
13 Jan 2026filed 14 Jan 2026	BBNX Beta BionicsMedical Devices	SEC FORM 4 Code A	—3,997 at $0.00	filing
13 Jan 2026filed 14 Jan 2026	BBNX Beta BionicsMedical Devices	SEC FORM 4 Code A	—3,997 at $0.00	filing
1 Dec 2025filed 2 Dec 2025	BBNX Beta BionicsMedical Devices	SEC FORM 4 Sold	$27K906 at $29.35	filing
1 Dec 2025filed 2 Dec 2025	BBNX Beta BionicsMedical Devices	SEC FORM 4 Sold	$15K500 at $29.91	filing
31 Oct 2025filed 5 Nov 2025	BBNX Beta BionicsMedical Devices	SEC FORM 4 Sold	$37K1,368 at $26.85	filing
31 Oct 2025filed 5 Nov 2025	BBNX Beta BionicsMedical Devices	SEC FORM 4 Sold	$1,05338 at $27.70	filing
15 Mar 2025filed 18 Mar 2025	BBNX Beta BionicsMedical Devices	SEC FORM 4 Code A	—11,247 at $0.00	filing
31 Jan 2025filed 3 Feb 2025	BBNX Beta Bionicsoption or derivative · Medical Devices	SEC FORM 4 Code A	—9,137 at $0.00	filing

News

BBNX DEADLINE ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important November 3 Deadline in Securities Class Action - BBNXBBNX · wallstreet-online.de · 22 Oct 2026 BETA BIONICS, INC. (NASDAQ: BBNX) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by November 3, 2026BBNX · prnewswire.com · 20 Oct 2026 Kaplan Fox Encourages Investors of Beta Bionics, Inc. (NASDAQ:BBNX) ...BBNX · pr-inside.com · 19 Oct 2026

0 headlines in the last 90 days name Adam Lezack; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care4

Buys in green, sells in red, by the company’s sector.

Related people

Mark HopmanChief Commercial Officer · Chief Commercial Officer at Beta Bionics, filing Form 4 there in the last year

Christy JonesDirector · Director at Beta Bionics, filing Form 4 there in the last year

Mike MensingerChief Product Officer · Chief Product Officer at Beta Bionics, filing Form 4 there in the last year

Sean SaintPresident & CEO · President & CEO at Beta Bionics, filing Form 4 there in the last year

Steven Jon RussellChief Medical Officer · Chief Medical Officer at Beta Bionics, filing Form 4 there in the last year

Stephen FeiderChief Financial Officer · Also traded BBNX in the last 90 days